Tenderwize
Retour à la recherche

Open-house rebate agreements for Nitrendipin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 162 days left·Open·Supplies
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nitrendipin, ATC C08CA08

52/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

52 / 100

Complexité

58 / 100

Facteurs de risque

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 31, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive supply/rebate agreements for pharmaceutical products containing Nitrendipin (ATC C08CA08).
  • Open-house model with uniform terms for all participating pharmaceutical companies.
Afficher le résumé complet

This is an open-house pharmaceutical supply notice for non-exclusive rebate agreements on the active substance Nitrendipin (ATC C08CA08) for AOK Rheinland-Pfalz/Saarland. The model is not a standard competitive public procurement, but the notice still sets formal submission and eligibility conditions. Contracts can start from 01.06.2025 and run for up to 24 months, with monthly entry possible during the term. No contract value is stated. Procurement documents are available via a URL, but no extracted contract document text was provided, so they were not analyzed.

Risques

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Only authorized and marketable medicines in Germany may be supplied under the contract.

Administrative

  • If the product is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided.
  • The AMIce extract must show name, MA holder or other marketing authorization basis, dosage form, active substance, and marketability.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreements for Nitrendipin

Single lot covering non-exclusive open-house rebate agreements for medicines containing the active substance Nitrendipin (ATC C08CA08). The scope excludes children’s medicines on the BfArM list under §35(5a) SGB V. The buyer states that terms are uniform for all participants, with no individual negotiations. Information in this lot comes from the structured data and XML notice.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 31, 2027

Détails de la procédure

Date de publication
10 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
236770-2025

Documents (1)

Appels d'offres similaires